Pre-op Avatrombopag Curbs Platelet Need in Patients With Liver Disease Pre-op Avatrombopag Curbs Platelet Need in Patients With Liver Disease

Pre-procedural avatrombopag (Doptelet, Dova) may reduce the need for platelet transfusions or rescue procedures for bleeding in patients with chronic liver disease (CLD) and thrombocytopenia, according to findings from two phase 3 trials.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news